Taurine metabolism: a potential target for neuroprotection in age-related neurodegenerative diseases

Abstract Taurine is one of the most abundant free amino acids in mammals and plays essential roles in cellular homeostasis, mitochondrial function, calcium regulation and neuronal survival. Taurine availability varies markedly across tissues, species and sexes, reflecting the balance between endogenous synthesis, dietary intake, transport and efflux. Although reduced taurine levels have been reported in some aging tissues, recent longitudinal studies indicate that circulating taurine does not decline universally with age, and its value as a biomarker of aging remains debated. Alterations in taurine or its transporter SLC6A6 have been described in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington’s disease and retinal degenerations. Preclinical studies indicate that taurine supplementation mitigates excitotoxicity, stabilizes mitochondrial function, reduces neuroinflammation and supports myelination and synaptic balance. Despite this strong mechanistic rationale, clinical evidence remains limited and heterogeneous, underscoring the need for biomarker-guided trials and a clearer definition of optimal therapeutic windows. In this review, we summarize the general properties of taurine and its metabolic regulation. We examine taurine’s neuroprotective properties across different neurodegenerative conditions and discuss future perspectives for targeting taurine metabolism as a promising but largely unexplored strategy for intervention in age-related neurodegenerative diseases.

Authors

Institutions

Publication Details

Journal
Mammalian Genome
Published
2026-11-16
DOI
https://doi.org/10.1007/s00335-026-10292-7
Primary Topic
Aldose Reductase and Taurine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Taurine metabolism: a potential target for neuroprotection in age-related neurodegenerative diseases

James R. Tribble, Rosario Amato, Pete A. Williams, Eleonora Daghini et al.
Mammalian Genome
Aldose Reductase and Taurine
article

Taurine metabolism: a potential target for neuroprotection in age-related neurodegenerative diseases

James R. Tribble, Rosario Amato, Pete A. Williams, Eleonora Daghini, Rune Brautaset
article en

Abstract

Abstract Taurine is one of the most abundant free amino acids in mammals and plays essential roles in cellular homeostasis, mitochondrial function, calcium regulation and neuronal survival. Taurine availability varies markedly across tissues, species and sexes, reflecting the balance between endogenous synthesis, dietary intake, transport and efflux. Although reduced taurine levels have been reported in some aging tissues, recent longitudinal studies indicate that circulating taurine does not decline universally with age, and its value as a biomarker of aging remains debated. Alterations in taurine or its transporter SLC6A6 have been described in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington’s disease and retinal degenerations. Preclinical studies indicate that taurine supplementation mitigates excitotoxicity, stabilizes mitochondrial function, reduces neuroinflammation and supports myelination and synaptic balance. Despite this strong mechanistic rationale, clinical evidence remains limited and heterogeneous, underscoring the need for biomarker-guided trials and a clearer definition of optimal therapeutic windows. In this review, we summarize the general properties of taurine and its metabolic regulation. We examine taurine’s neuroprotective properties across different neurodegenerative conditions and discuss future perspectives for targeting taurine metabolism as a promising but largely unexplored strategy for intervention in age-related neurodegenerative diseases.

Mammalian GenomeVol. 38(1)
University of Pisa (IT), King's College London (GB), Karolinska Institutet (SE), The Royal Victorian Eye & Ear Hospital (AU), Centre for Eye Research Australia (AU), S:t Eriks Ögonsjukhus (SE)
Aldose Reductase and Taurine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon